Combined Nicotinamide Riboside and Home-Based Exercise Improved Peak VO2 Safely in Friedreich’s Ataxia
Highlights
In this single-centre, 2 × 2 factorial, randomised phase 2 trial, the combination of nicotinamide riboside and individualized home-based exercise improved peak oxygen consumption over 12 weeks in patients with Friedreich’s ataxia compared with placebo and no exercise.
The adjusted between-group difference in change in peak VO2 for combination therapy versus control was 0.21 L/min (95% CI 0.05 to 0.36; padjusted=0.0299), meeting the study’s prespecified efficacy threshold in stage 1 analysis.
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.